Psychiatry and Neurology, Neurology · New Orleans, LA
NPI
1245255371
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1415 Tulane Ave Fl 5
New Orleans, LA, 70112
Phone (504) 988-5561
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
153 services
Medicare patients, 2024
48
Average age 63
Drug cost, 2024
$1.7M
584 prescriptions
Company payments, 2025
$79
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth C Crabtree was code 99215 (office e&m - established), 54 times for 21 patients. In total Elizabeth C Crabtree billed 153 services in 13 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 54 | 21 | $106.81 | $5,768 |
| 99214 Office E&M - Established | Facility | 27 | 16 | $71.03 | $1,918 |
By year: 2022 $9,179 for 116 services; 2023 $13K for 157 services; 2024 $12K for 153 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth C Crabtree prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 64 prescriptions and refills. In total Elizabeth C Crabtree wrote 584 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 64 | 76 | 13 | $27K |
| Teriflunomide Generic | 33 | 33 | Under 11 | $1,494 |
| Baclofen Generic | 29 | 41 | Under 11 | $397 |
| Gabapentin Generic | 29 | 41 | Under 11 | $260 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 19 | 19 | Under 11 | $145K |
| Cyclobenzaprine Hcl Generic | 17 | 21 | Under 11 | $68.24 |
| Escitalopram Oxalate Generic | 17 | 21 | Under 11 | $81.68 |
| Enspryng Satralizumab-Mwge | 16 | 25 | Under 11 | $440K |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 16 | 16 | Under 11 | $337K |
| Sodium Chloride 0.9 % Sodium Chloride | 15 | 25 | Under 11 | $86.29 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 14 | 14 | Under 11 | $196K |
| Myrbetriq Mirabegron | 14 | 16 | Under 11 | $6,950 |
| Solifenacin Succinate Generic | 14 | 24 | Under 11 | $478 |
| Fingolimod Fingolimod Hcl | 13 | 13 | Under 11 | $7,288 |
| Lacosamide Generic | 13 | 19 | Under 11 | $292 |
Brand drugs: 150 claims; generic drugs: 434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth C Crabtree $79 ($79 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genentech USA, Inc. with $34.42.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.